Vimarsana
Biggest News Aggregation in the World

Page 10 - Mathilde Bohin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mathilde Bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mathilde Bohin Today - Breaking & Trending Today

ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update - Vimarsana News

ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Erytech Pharma S.A.March 4, 2021 GMT ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Lyon (France) and Cambridge, MA (U.S.), March 4, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fourth qua...

Source: apnews.com
IMPLANET: Implanet Reports an Improvement in Its 2020 Results - Vimarsana News

IMPLANET: Implanet Reports an Improvement in Its 2020 Results

IMPLANET: Implanet Reports an Improvement in Its 2020 Results Gross margin improvement to 58.2%, versus 56% in 2019 Strengthened cash position Regulatory Nws: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, announces its results for the financial year to December 31, 2020, approved by the Board of Directors on February 16, 2021. " Within the very unique public health context that affected 2020, we generated over 6 million euros in revenue and continued to...

Implanet Announces 2020 Revenue of €6 Million - Vimarsana News

Implanet Announces 2020 Revenue of €6 Million

Implanet Announces 2020 Revenue of €6 Million Fourth quarter JAZZ sales up 9% compared with the fourth quarter of 2019, with 34% growth in the United States Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, today announced its provisional unaudited fourth-quarter revenue, annual revenue and cash position at December 31, 2020. Ludovic Lastennet, Implanet's Chief Executive Officer, commented: " Although down versus prior year, our revenue ...

Implanet Enters Into Exclusive Negotiations for the Acquisition of a European Manufacturer of Implants for Spine Surgery, and Signs a Financing - Vimarsana News

Implanet Enters Into Exclusive Negotiations for the Acquisition of a European Manufacturer of Implants for Spine Surgery, and Signs a Financing

THIS PRESS RELEASE SHOULD NOT BE PUBLISHED OR DISTRIBUTED, EITHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA This acquisition would allow the Company to

ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Vimarsana News

ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference Erytech Pharma S.A.January 6, 2021 GMT ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference Lyon (France) and Cambridge, MA (U.S.), January 6, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced today that CEO, Gil Beyen, will present at the H.C....

Source: apnews.com